These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20004976)

  • 61. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection.
    Loong CC; Hsieh HG; Lui WY; Chen A; Lin CY
    J Pathol; 2002 Jul; 197(3):322-32. PubMed ID: 12115878
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats.
    Ueda H; Takahara S; Azuma H; Kusaka M; Suzuki S; Katsuoka Y
    Eur Surg Res; 2000; 32(5):279-83. PubMed ID: 11111172
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pivotal Advance: Up-regulation of acetylcholine synthesis and paracrine cholinergic signaling in intravascular transplant leukocytes during rejection of rat renal allografts.
    Hecker A; Mikulski Z; Lips KS; Pfeil U; Zakrzewicz A; Wilker S; Hartmann P; Padberg W; Wessler I; Kummer W; Grau V
    J Leukoc Biol; 2009 Jul; 86(1):13-22. PubMed ID: 19201987
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intragraft events preceding chronic renal allograft rejection in a modified tolerance protocol.
    Shimizu A; Yamada K; Sachs DH; Colvin RB
    Kidney Int; 2000 Dec; 58(6):2546-58. PubMed ID: 11115090
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
    Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
    Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
    Li F; Zhang X; Gordon JR
    Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monocytes in the rat: phenotype and function during acute allograft rejection.
    Steiniger B; Stehling O; Scriba A; Grau V
    Immunol Rev; 2001 Dec; 184():38-44. PubMed ID: 12086320
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Local immunosuppressive therapy with monoclonal anti-T cell antibody on renal allograft survival in the rat.
    Lee CJ; Yoshimura N; Shiho O; Kita M; Oka T
    Clin Exp Immunol; 1993 Mar; 91(3):362-7. PubMed ID: 7680292
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-inflammatory effects of alphav integrin antagonism in acute kidney allograft rejection.
    Bedke J; Kiss E; Behnes CL; Popovic ZV; Heuser M; Stojanovic T; Sijmonsma T; Huber P; Domhan S; Muschal S; Abdollahi A; Gretz N; Gröne HJ
    Am J Pathol; 2007 Oct; 171(4):1127-39. PubMed ID: 17702892
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
    Azuma H; Chandraker A; Nadeau K; Hancock WW; Carpenter CB; Tilney NL; Sayegh MH
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12439-44. PubMed ID: 8901600
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibodies against mesangial cells in a rat model of chronic renal allograft rejection.
    Joosten SA; van Ham V; Borrias MC; van Kooten C; Paul LC
    Nephrol Dial Transplant; 2005 Apr; 20(4):692-8. PubMed ID: 15701669
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy.
    Kühne L; Jung B; Poth H; Schuster A; Wurm S; Ruemmele P; Banas B; Bergler T
    BMC Immunol; 2017 Dec; 18(1):52. PubMed ID: 29258420
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection.
    McGrath JS; Shehata M
    Transplant Proc; 2001 May; 33(3):2191-2. PubMed ID: 11377499
    [No Abstract]   [Full Text] [Related]  

  • 75. Tolerance induction by intrathymic inoculation prevents chronic renal allograft rejection.
    Blom D; Morrissey N; Mesonero C; Zuo XJ; Jordan S; Fisher T; Bronsther O; Orloff MS
    Transplantation; 1998 Jan; 65(2):272-5. PubMed ID: 9458029
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Macrophages act as effectors of tissue damage in acute renal allograft rejection.
    Jose MD; Ikezumi Y; van Rooijen N; Atkins RC; Chadban SJ
    Transplantation; 2003 Oct; 76(7):1015-22. PubMed ID: 14557746
    [TBL] [Abstract][Full Text] [Related]  

  • 77. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Control of monocyte influx in glomerulonephritis in transplanted kidneys in the rat.
    De Heer E; Prodjosudjadi W; Davidoff A; van der Wal A; Bruijn JA; Paul LC
    Lab Invest; 1998 Oct; 78(10):1327-37. PubMed ID: 9800958
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.
    Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR
    Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Designing CXCL8-based decoy proteins with strong anti-inflammatory activity in vivo.
    Falsone A; Wabitsch V; Geretti E; Potzinger H; Gerlza T; Robinson J; Adage T; Teixeira MM; Kungl AJ
    Biosci Rep; 2013 Sep; 33(5):. PubMed ID: 23919527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.